Clinical Trials Browser

Approved for marketing × EGFRm Advanced Non-Small Cell Lung Cancer × 1 year × Clear all

NCT06279728 2025-07-03

Medical Access Program for Datopotamab Deruxtecan in EGFRm NSCLC Patients

Approved for marketing

EGFRm Advanced Non-Small Cell Lung Cancer